OXYCONTIN

This brand name is authorized in Austria, Australia, Brazil, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Japan, Mexico, Netherlands, New Zealand, Poland, Singapore, United Kingdom, United States, South Africa

Active ingredients

The drug OXYCONTIN contains one active pharmaceutical ingredient (API):

1 Oxycodone UNII C1ENJ2TE6C - OXYCODONE HYDROCHLORIDE

Oxycodone is a full opioid agonist with no antagonist properties. It has an affinity for kappa, mu and delta opioid receptors in the brain and spinal cord. Oxycodone is similar to morphine in its action. The therapeutic effect is mainly analgesic, anxiolytic, antitussive and sedative. Read about Oxycodone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
OXYCONTIN Film-coated, extended release tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N02AA05	Oxycodone	N Nervous system → N02 Analgesics → N02A Opioids → N02AA Natural opium alkaloids
Discover more medicines within N02AA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 12510K, 12518W, 12525F, 12527H, 12538X, 12545G, 8385H, 8386J, 8387K, 8388L, 9399Q, 9400R
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 556716100000007, 556716100000107, 556716100000307, 556716100000507
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 25.837-08-04, 25.850-08-04, 25.851-08-04
Country: EE	Ravimiamet	Identifier(s): 1043165, 1043176, 1043187, 1043198, 1075531, 1075542, 1075553, 1080582, 1080593, 1080605, 1080616, 1080627, 1080638, 1080649, 1080650, 1080661, 1402557, 1402568, 1402579, 1402580, 1402591, 1402603, 1402614, 1402625
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 63446, 63447, 63448, 63449, 68605
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 166167, 440389, 516003, 534415, 569650, 586800, 586966, 587113
Country: FR	Base de données publique des médicaments	Identifier(s): 61200108, 61287223, 62557732, 64681077, 65129174, 66424640, 67467071, 67619878, 68490105
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 162197, 162199, 162201, 162203, 162205, 186044, 186048, 186050, 186418, 186436, 186448, 186452, 28919, 28967, 28974, 28983, 381583, 381586, 381588, 40752
Country: HK	Department of Health Drug Office	Identifier(s): 59570, 59571, 59572, 59573, 59574, 66290, 66291, 66292, 66293, 66294, 66295, 66296
Country: IE	Health Products Regulatory Authority	Identifier(s): 59124, 59137, 59166, 59182, 59198
Country: JP	医薬品医療機器総合機構	Identifier(s): 8119002G5020, 8119002G6026, 8119002G7022, 8119002G8029
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 387M97
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 57614, 57622, 57630, 57649, 66788, 94277, 94285, 94293, 94307
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 15600, 15601, 15602, 15603, 15604, 15605, 15606
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100192812, 100192829, 100192835, 100192841, 100192858
Country: SG	Health Sciences Authority	Identifier(s): 13076P, 13077P, 13078P, 13080P, 13082P, 14884P, 14885P, 14886P, 14887P, 14888P
Country: US	FDA, National Drug Code	Identifier(s): 59011-410, 59011-415, 59011-420, 59011-430, 59011-440, 59011-460, 59011-480
Country: ZA	Health Products Regulatory Authority	Identifier(s): 41/2.9/1098, 41/2.9/1099, 41/2.9/1100, 41/2.9/1101, 41/2.9/1102